Vaccine Intellectual Property.
Affordable access
Immunization
Patent
U.S. Patent and Trademark Office
Vaccine technology
World Health Organization
Journal
Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
17
12
2021
pubmed:
18
12
2021
medline:
21
1
2022
Statut:
ppublish
Résumé
We analyzed the intellectual property landscape surrounding currently available vaccines, with a focus on patents.
Identifiants
pubmed: 34918266
doi: 10.1007/978-1-0716-1892-9_29
doi:
Substances chimiques
Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
519-525Informations de copyright
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Stevens H, Huys I, Debackere K, Goldman M, Stevens P, Mahoney RT (2017) Vaccines: accelerating innovation and access. World Intellectual Property Organization global challenges report
Rutschman AS (2019) The vaccine race in the twenty-first century. Ariz Law Rev 61:729
Purvis SA (2013) Basics of patent protection, World Intellectual Property Organization
U.S. Patent & Trademark Office, General Information Concerning Patents (2015)
World Intellectual Property Organization (2013). Handbook on industrial property information and documentation: glossary of terms concerning industrial property Information and Documentation, 8.1.18
Friede M (2010) Intellectual property and license management with respect to vaccines. World Health Organization
Padmanabhan S, Amin T, Sampat B, Cook-Deegan R, Chandrasekharan S (2010) Intellectual property, technology transfer and developing country manufacture of low-cost HPV vaccines—a case study of India. Nat Biotechnol 28(7):671–678
doi: 10.1038/nbt0710-671
World Intellectual Property Organization (2012) Patent landscape report on vaccines for selected infectious diseases
35 U.S.C. § 101
Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013)
Alice Corp. v. CLS Bank international, 573 US 208, 217–18 (2014)
Laws of Nature, Natural Phenomena & Products of Nature, Manual of Patent Examining Procedure, 28
35 U.S.C. § 102
35 U.S.C. § 103
Manual of Patent Examining Procedure, 2153.01(a)
Manual of Patent Examining Procedure, 2141
Manual of Patent Examining Procedure, 2107
Agreement on Trade-Related Aspects of Intellectual Property Rights (1994), article 33
35 U.S.C. § 154
Uniform Trade Secrets Act (1979, last amended 1985)
Kesselheim AS, Mello MM (2007) Confidentiality laws and secrecy in medical research: improving public access to data on drug safety. Health Aff 26(2):483–491
doi: 10.1377/hlthaff.26.2.483
Digitech Image Techs., LLC v. Elecs. for Imaging, Inc., 758 F.3d 1344, 1349–50 (Federal Circuit, 2014)